Oncology Intelligence Digest November 13, 2026 On November 10, the FDA approved Merck KGaA’s pimicotinib (Pimjetmi) for tenosynovial…
Oncology Intelligence Digest November 13, 2026 On November 10, the FDA approved Merck KGaA’s pimicotinib (Pimjetmi) for tenosynovial…